U.S. Markets open in 31 hrs, 21 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 15.36 09:30 AM EST | |
|---|---|---|
| Day High | 15.73 10:01 AM EST |
|
| Range | 0.37 |
| Volume | 356,862 | |
|---|---|---|
| 30-Day Avg Vol | 590,000 |
|
| Difference | -39.51% |
| Market Cap | 1.26 B | |
|---|---|---|
| Mkt Cap Chg | 18.51 M |
| Shares Out | 80.49 M | |
|---|---|---|
| % Shrs Traded | 0.44% | |
| 1yr EPS Est | -1.399 |
| 52-Wk Low | 11.81 | |
|---|---|---|
| 52-Wk High | 23.49 |
|
| Range | 11.68 |
| Prev Close | 15.48 11/5/09 | |
|---|---|---|
| Today's Open | 15.36 | |
| Change | -0.78% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3.98 M |
| Revenue (LFY) | 238.45 M | |
|---|---|---|
| Earnings (LFY) | -82.71 M | |
| Earnings (MRQ) | -1.02 M | |
| Next Earn Est | -0.302 | |
| Next Earnings | 02/22/2010 |
|
| EPS (TTM) | -0.79 | |
| 1yr EPS Growth | -70.61% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -11.00 | |
| PEG Ratio | — | |
| Return on Equity | -18.95 | |
| Beta | 1.25 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Regeneron isn't the Pentagon, but the company is fighting some serious enemies. Regeneron Pharmaceuticals develops protein-based drugs used to battle a variety of diseases and conditions, including cancer, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.302 2/22/10 | — — |
—
—
|
| Last Quarter | -0.206 9/30/09 | -0.01 9/30/09 |
0.196
Beat
|
| 2 Quarters Ago | -0.283 6/30/09 | -0.19 6/30/09 |
0.093
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 117.46 M | 238.46 M |
| Gross Profit | 113.39 M | -40.48 M |
| Operating Income | -1.29 M | -89.83 M |
| Net Income | -1.02 M | -82.71 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts